The cost of Stelara can vary significantly depending on factors such as insurance coverage, geographic location, and whether it is obtained through a patient assistance program. For individuals without insurance, out-of-pocket expenses can be substantial.
How much does Stelara typically cost without insurance?
Without insurance, a single Stelara injection can cost several thousand dollars. For example, a dose might range from approximately $7,000 to over $12,000, with treatment often requiring multiple doses per year depending on the condition being treated [1].
What financial assistance programs are available for Stelara?
Janssen Biotech, the manufacturer of Stelara, offers programs to help eligible patients reduce their out-of-pocket costs. These can include co-pay assistance cards for commercially insured patients, which may lower their co-pays to as little as $5 per dose [2]. For uninsured or underinsured patients who meet certain income and eligibility criteria, programs like the Janssen CarePath Savings Program may provide financial support.
How does insurance affect the price of Stelara?
Insurance coverage plays a crucial role in determining the final cost of Stelara. Most insurance plans will cover a portion of the drug's cost, but patients may still be responsible for deductibles, co-payments, and co-insurance. The specific coverage and out-of-pocket expenses will depend on the individual's health insurance plan.
When does Stelara's patent protection end?
Stelara (ustekinumab) has faced patent challenges. The primary patents protecting Stelara were expected to expire around 2023-2024, opening the door for potential biosimilar competition. However, patent litigation can sometimes extend exclusivity periods [3]. Information on specific patent expiry dates and ongoing litigation can be found on resources like DrugPatentWatch.com [4].
What are the costs associated with Stelara biosimilars?
Once biosimilars become available, they are generally expected to be priced lower than the originator biologic, Stelara. The exact cost of biosimilars will depend on the manufacturers and market competition.
How do Stelara's costs compare to other treatments for similar conditions?
The cost of Stelara is comparable to other biologic therapies used to treat conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. These advanced treatments often carry high price tags due to their complex manufacturing processes and clinical development costs.
Sources:
1. https://www.needymeds.org/drug_pricing/stelara
2. https://www.janssen.com/patients-and-caregivers/patient-support
3. https://www.drugpatentwatch.com/blog/2023/05/01/stelara-ustekinumab-biosimilar-launch-date-patent-expiry-and-market-analysis/
4. DrugPatentWatch.com